Balaji Gandhi Sells 1,827 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) CFO Balaji Gandhi sold 1,827 shares of Phreesia stock in a transaction dated Wednesday, March 26th. The shares were sold at an average price of $27.46, for a total value of $50,169.42. Following the transaction, the chief financial officer now owns 103,591 shares of the company's stock, valued at $2,844,608.86. The trade was a 1.73 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Balaji Gandhi also recently made the following trade(s):

• On Tuesday, February 18th, Balaji Gandhi sold 5,771 shares of Phreesia stock. The stock was sold at an average price of $30.04, for a total transaction of $173,360.84.
• On Thursday, February 13th, Balaji Gandhi sold 28,759 shares of Phreesia stock. The shares were sold at an average price of $30.00, for a total transaction of $862,770.00.
• On Monday, January 27th, Balaji Gandhi sold 4,813 shares of Phreesia stock. The shares were sold at an average price of $27.48, for a total transaction of $132,261.24.
• On Tuesday, January 21st, Balaji Gandhi sold 5,827 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total transaction of $159,135.37.
• On Wednesday, January 15th, Balaji Gandhi sold 836 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total value of $22,555.28.
• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total value of $85,018.95.

Phreesia Price Performance

Shares of PHR stock traded down $0.10 during trading hours on Tuesday, reaching $25.46. The company had a trading volume of 420,332 shares, compared to its average volume of 428,473. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $30.53. The company has a market capitalization of $1.50 billion, a price-to-earnings ratio of -17.32 and a beta of 1.03. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. The stock has a fifty day moving average of $27.31 and a 200-day moving average of $24.21.

Remove Ads

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on PHR. Canaccord Genuity Group upped their target price on Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research note on Thursday, March 13th. KeyCorp upped their price objective on shares of Phreesia from $28.00 to $30.00 and gave the stock an "overweight" rating in a research report on Wednesday, January 8th. Truist Financial increased their price objective on shares of Phreesia from $31.00 to $34.00 and gave the company a "buy" rating in a report on Wednesday, December 11th. JMP Securities reissued a "market outperform" rating and set a $30.00 target price on shares of Phreesia in a research note on Tuesday, December 10th. Finally, Piper Sandler reaffirmed an "overweight" rating and issued a $33.00 price target (up from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Phreesia has a consensus rating of "Buy" and a consensus target price of $31.33.

Institutional Trading of Phreesia

Hedge funds and other institutional investors have recently modified their holdings of the stock. Johnson Financial Group Inc. grew its holdings in shares of Phreesia by 381.3% in the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after purchasing an additional 896 shares during the period. R Squared Ltd purchased a new stake in shares of Phreesia in the 4th quarter valued at approximately $30,000. BankPlus Trust Department acquired a new stake in shares of Phreesia during the 4th quarter worth approximately $34,000. Quarry LP raised its position in shares of Phreesia by 210.9% during the 4th quarter. Quarry LP now owns 2,835 shares of the company's stock valued at $71,000 after buying an additional 1,923 shares during the period. Finally, Venturi Wealth Management LLC acquired a new position in Phreesia in the fourth quarter valued at approximately $76,000. 92.10% of the stock is owned by institutional investors and hedge funds.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.